SAN FRANCISCO - The fewer-than-expected demonstrators who showed up at the BIO 2004 International Convention may have gained the media coverage they came for, panel sessions proved intriguing, and the exhibit hall was full of life, but the real activity likely went on behind the scenes. Read More
The National Institutes of Health agreed to pay Kalypsys Inc. up to $30 million over four years for access to the firm's technology, which is expected to help scientists efficiently and simultaneously screen a broad portfolio of biological assays. (BioWorld Today) Read More
